"HEMP STEEL REBARS... Stronger Than Steel?"

Researchers from Rensselaer Polytechnic Institute,confirm that hemp rebar could be a suitable alternative to steel in cement construction.

Dan Walczyk, director of the manufacturing innovation center and Alex Tsamis, associate director of the Architecture Science & Ecology Center, say they have produced an alternative to steel in concrete buildings and various infrastructure projects.

Both scientists agree that hemp-based natural fiber-reinforced thermoplastic rebar has the potential to displace steel as the most preferred reinforcing technology in a few years. These hemp rebars are partially guaranteed to eliminate corrosion challenges, and they are more durable than steel bars.

Rebar is a crucial component in the frameworks of cement buildings. They help construct perfectly standing and durable skeletal frameworks for convention infrastructure projects. On its own, concrete lacks tensile strength, and this is the primary reason why rebars are used—to provide tensile strength.

The Manufacturing Potential of Hemp

About 150 years ago, before the onset of cannabis prohibition and the criminalization of offenders, hemp was used to produce over 75% of the goods consumed by Americans. The manufacturing of hemp-derived goods was scrapped when the government banned the cultivation and usage of the drug based on the threat of abuse. Currently, hemp is at the forefront of manufacturing discussions due to its undeniable potential to serve humans and the global ecosystem.

"Cannabidiol as effective as antipsychotic meds with fewer side effects".

Schizophrenia is a mental disorder that affects a person’s ability to think, feel, and behave clearly. 

It can cause psychotic episodes, and treatment is usually lifelong and involves antipsychotic medications with toxic side effects.

In 2012, researchers published a study in Translational Psychiatry showing that a CBD isolate can treat schizophrenia as effectively as antipsychotic pharmaceuticals — and with far fewer side effects.

In this study, researchers led by Markus Leweke, MD, of the University of Cologne in Germany recruited 39 people with schizophrenia who were hospitalized for a psychotic episode.

"GPR55 The third Cannabinoid Receptor (CB3)"

Finding the CB3 receptor could mean huge medical advancements for cannabis medicine.Originally called GPR55 after the gene that encodes it, the CB3 receptor is an exciting discovery for science. It is now clear this receptor is part of the Endocannabinoid System and interacts with endocannabinoids and phtyocannabinoids like THC and CBD.

Every animal, have an Endocannabinoid System. Cannabinoid receptors are found throughout the body. But where has CB3 been hiding? Well, turns out it hasn’t exactly been hiding. It’s more like researchers didn’t connect it to endocannbinoid activity before now.

Firstly, the two most researched receptors are CB1 and CB2. While CB1 receptors are prominent in the central nervous system, and CB2 receptors typically reside in the immune system. CB3 receptors were incognito, previously identified as GPR55. At first, science didn’t know that this receptor even accepted cannabinoids.

The CB3 receptor stayed hidden from scientists because it’s so unlike the other cannabinoid receptors. It only shares 13% of amino acid identity with them. It simply doesn’t look like it would react with cannabis, so scientists on the hunt for new cannabinoid receptors passed over it for years. This designation means that while the receptor had been found, science doesn’t yet know what activated that receptor.

When CB3 was first discovered in 1999, many doubted it was a cannabis receptor. It wasn’t until real proof came along years later that medical researchers accepted that GPR55 was indeed the 3rd Cannabinoid Receptor.

"SAFE & LEGAL ACCESS TO MEDICAL CANNABIS AND CANNABIDIOL (CBD)"

While not everyone with epilepsy should or would consider medical cannabis or cannabidiol (CBD) as a treatment option, some people living with uncontrolled seizures have reported beneficial effects and reduced seizure activity when using medical cannabis, especially strains rich in CBD. Further research is needed on the effects of medical cannabis on epilepsy, but when recommended by a treating physician, medical cannabis may be the best alternative for some individuals living with drug-resistant epilepsy and uncontrolled seizures.

Access to medical cannabis will support increased research efforts and allow individuals who have failed to gain seizure control an option for treatment.

"Alcohol, Not Cannabis, Associated with Violent Behaviors in Psychotic Patients"

The consumption of alcohol, but not cannabis, is associated with an increased likelihood of impulsiveness and violent behavior among subjects with schizophrenic spectrum disorders, according to data published in the Journal of Clinical Psychopharmacology.

The link between substances of abuse, impulsivity, and violence in psychotic patients remains unclear but a team of Canadian and Italian investigators assessed the relationship between the use of alcohol and cannabis on psychotic, impulsive, and violent behavior in a cohort of subjects diagnosed with either schizophrenia or other psychotic disorders

The term "psychotic disorder" refers to a person's thought dysfunction and is often described as "the patient's loss of contact with reality."

This study aims at unraveling whether cannabis use disorder is associated with violent and/or psychotic behavior in patients who where hospitalized in a high-security hospital.